Our pioneering Psychedelic Practitioner Training Program offers a 12-month immersive experience designed for clinicians and professionals committed to the future of mental health care. This comprehensive program bridges clinical expertise with safe, ethical, and effective psychedelic practices, covering modalities like ketamine, MDMA, huachuma, and psilocybin in therapeutic settings.

SoundMind Institute 12-month psychedelic program, highlighted in Forbes, starts this fall. Don’t miss this chance to advance your career!

Thank you to everyone who joined our webinar on psilocybin legalization efforts in New York, New Jersey, and Colorado. We had an incredible discussion led by Dr. Hannah McLane and our esteemed panelists: Allison Hoots, Esq., Tasia Poinsatte, Joshua Kappel, Esq., the Honorable Jeannine LaRue, Joseph Shapiro, Esq., Lisa Gora, Esq., and Sara Price, BSN, RN, NC-BC.

Missed the webinar or want to revisit the insights shared? Watch the webinar here

New York, New Jersey, and Colorado each have psilocybin legalization efforts underway this summer. What is happening in each state? What are the differences? How can you help? What does this mean for the people living in each state?

To discuss these developments further, SoundMind has put together an incredible panel of experts from each state hosted by Dr. Hannah McLane. Our panelists include Allison Hoots, Esq., Tasia Poinsatte, Joshua Kappel, Esq., the Honorable Jeannine LaRue, Joseph Shapiro, Esq., Lisa Gora, Esq., and Sara Price, BSN, RN.

On June 6, 2024, Dr. Hannah McLane testified to the NJ Senate Health Committee to support New Jersey’s ongoing efforts at legalizing psilocybin access. You can read the current version of the bill here on New Jersey’s legislative website.